man colon cancer cells evolve and specifically how they become immune to inhibitor therapy treatment. Their research was conducted at the request of the Pathology and Oncology Department at John Hopkins University. The Department was trying to understand how the KRAS gene in colon cancer cells becomes activated after inhibitor drug